Literature DB >> 7059420

Antipyrine elimination in saliva after low-dose combined or progestogen-only oral contraceptive steroids.

D M Chambers, G C Jefferson, M Chambers, N B Loudon.   

Abstract

1 A 'low-dose' combined oral contraceptive steroid (OCS) preparation containing 30 microgram ethinylo-estradiol and 150 microgram levonorgestrel was found to reduce significantly antipyrine clearance in a group of women acting as their own controls. 2 An OCS preparation containing only a progestogen (75 microgram norgestrel) did not reduce antipyrine clearance in a second group of women. 3 The evidence suggesting that the oestrogen component of combined OCS preparations could be responsible for the reduction in antipyrine clearance is discussed.

Entities:  

Keywords:  Biology; Comparative Studies; Contraception; Contraceptive Agents; Contraceptive Agents, Estrogen; Contraceptive Agents, Female; Contraceptive Agents, Progestin; Contraceptive Methods; Endocrine System; Estrogens; Ethinyl Estradiol; Family Planning; Hormones; Levonorgestrel; Literature Review; Norgestrel; Oral Contraceptives; Oral Contraceptives, Combined; Oral Contraceptives, Low-dose; Physiology; Research Methodology; Studies

Mesh:

Substances:

Year:  1982        PMID: 7059420      PMCID: PMC1401993          DOI: 10.1111/j.1365-2125.1982.tb01362.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  18 in total

Review 1.  Sex as a factor in metabolism, toxicity, and efficacy of pharmacodynamic and chemotherapeutic agents.

Authors:  F C Goble
Journal:  Adv Pharmacol Chemother       Date:  1975

2.  Studies on the disposition of antipyrine, aminopyrine, and phenacetin using plasma, saliva, and urine.

Authors:  E S Vesell; G T Passananti; P A Glenwright; B H Dvorchik
Journal:  Clin Pharmacol Ther       Date:  1975-09       Impact factor: 6.875

3.  Assessment of antipyrine kinetics by measurement in saliva.

Authors:  H S Fraser; J C Mucklow; S Murray; D S Davies
Journal:  Br J Clin Pharmacol       Date:  1976-04       Impact factor: 4.335

4.  Environmental effects on antipyrine half-life in man.

Authors:  H S Fraser; J C Mucklow; C J Bulpitt; C Khan; G Mould; C T Dollery
Journal:  Clin Pharmacol Ther       Date:  1977-11       Impact factor: 6.875

5.  Effect of oral contraceptives on drug metabolism.

Authors:  D E Carter; J M Goldman; R Bressler; R J Huxtable; C D Christian; M W Heine
Journal:  Clin Pharmacol Ther       Date:  1974-01       Impact factor: 6.875

6.  Impairment of human drug metabolism by oral contraceptive steroids.

Authors:  K O'Malley; I H Stevenson; J Crooks
Journal:  Clin Pharmacol Ther       Date:  1972 Jul-Aug       Impact factor: 6.875

7.  Increased antipyrine half-life in women taking oral contraceptives.

Authors:  K O'Malley; I H Stevenson; W Alexander
Journal:  Scott Med J       Date:  1970-12       Impact factor: 0.729

8.  Relationship between plasma antipyrine half-lives and hepatic microsomal drug metabolism in dogs.

Authors:  E S Vesell; C J Lee; G T Passananti; C A Shively
Journal:  Pharmacology       Date:  1973       Impact factor: 2.547

9.  Effect of oral contraceptives on plasma clearance.

Authors:  D E Carter; R Bressler; M R Hughes; M R Haussler; D Christian; M W Heine
Journal:  Clin Pharmacol Ther       Date:  1975-12       Impact factor: 6.875

10.  Modification of the anticholinesterase action of 0,0-diethyl 0-(4-methylthio-M-tolyl) phosphorothioate (DMP) by drugs affecting hepatic microsomal enzymes.

Authors:  K P Dubois; F Kinoshita
Journal:  Arch Int Pharmacodyn Ther       Date:  1965-08
View more
  3 in total

Review 1.  Clinical pharmacokinetics of oral contraceptive steroids.

Authors:  M L Orme; D J Back; A M Breckenridge
Journal:  Clin Pharmacokinet       Date:  1983 Mar-Apr       Impact factor: 6.447

2.  Lack of effect of oral contraceptive use on the pharmacokinetics of quinine.

Authors:  S Wanwimolruk; S Kaewvichit; O Tanthayaphinant; C Suwannarach; A Oranratnachai
Journal:  Br J Clin Pharmacol       Date:  1991-02       Impact factor: 4.335

3.  Influence of sex and oral contraceptive steroids on paracetamol metabolism.

Authors:  J O Miners; J Attwood; D J Birkett
Journal:  Br J Clin Pharmacol       Date:  1983-11       Impact factor: 4.335

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.